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Morphine-induced macrophage activity modulates mesangial cell pro-
liferation and matrix synthesis. Glomerular mesangial injury is the
predominant renal lesion in patients with heroin addiction. We studied the
effect of morphine (an active metabolite of heroin) activated macrophages
on mesangial cell (MC) proliferation and matrix synthesis. We prepared
conditioned media containing either vehicle alone (CSP), macrophage
secretory products (MSP) and secretory products of morphine treated
macrophages (M-MSP). M-MSP increased (P < 0.01) the proliferation of
MC when compared with MSP alone. M-MSP increased synthesis of
laminin by MC at concentrations of 10 to 50% when compared with cells
treated with MSP alone (at 50% concentration, MSP, 126 19 vs.
M-MSP, 312 14 ng/mg protein, P < 0.001). M-MSP also increased the
synthesis of collagen type IV by MC. This effect of M-MSP was attenuated
(P < 0.05) by anti-TGF-3 antibodies. Since M-MSP also increased mRNA
expression for TGF-/3 by MC, it appears that the effect of M-MSP on MC
may be mediated through the generation of TGF-3.
Focal glomeruloscierosis is the predominant glomerular lesion
in patients with heroin addiction [1]. The glomerular mesangium
is the main site of injury in this lesion. The mesangium consists of
mesangial cells and extracellular mesangial matrix (ECM).
Eighty-five to 95% of mesangial cells are similar to smooth muscle
cells and the remaining 5 to 15% are bone marrow derived
macrophages [2, 3]. We hypothesized that interactions between
macrophages and morphine (an active metabolite of heroin)
either in the blood or in the mesangium may contribute to
glomerular mesangial injury.
Expansion of the glomerular mesangium has been demon-
strated to be a precursor of glomerulosclerosis [2]. Mesangial
expansion can occur either as a result of mesangial cell prolifer-
ation or enhanced deposition of ECM or both. Macrophages seem
to play an important role in the development of mesangial
expansion as shown in the experimental animal models of glomer-
ulosclerosis [4—91. We hypothesize that in patients with drug
addiction, morphine can activate monocytes (either circulating in
the blood or residing in the mesangium) to secrete specific
products which may activate mesangial cells to proliferate and
synthesize matrix.
Received for publication February 3, 1995
and in revised form August 7, 1995
Accepted for publication August 7, 1995
© 1996 by the International Society of Nephrology
94
We prepared conditioned media from macrophages in the
presence or absence of morphine and evaluated the effects of
these conditioned media on the proliferation of mesangial cells. In
addition, we determined the effects of these media on the
synthesis of extracellular matrix components including laminin
and collagen by mesangial cells. Recently, transforming growth
factor (TGF)-13 was demonstrated to play an important role in the
progression of glomeruloscierosis [6]. Therefore, we also studied
mRNA expression for TGF-13 by mesangial cells under control as
well as stimulated states. Our in vitro studies provide a basis for
speculation in the role of morphine-macrophage interactions in
heroin-induced nephropathy development.
Methods
Culture of glomerular mesangial cells
The culture of rat glomerular MC was carried out as previously
described [10—12]. After three weeks in primary culture, MC were
detached from the flask by adding a 0.25% trypsin EDTA solution
(Sigma Chemical Co. St. Louis, MO, USA) and transferred to a
plastic flask containing 5 ml of incubation medium including
RPMI 1640 (Sigma), penicillin (50 U/ml), streptomycin sulfate (50jig/ml)(Sigma) and 10% fetal calf serum (FCS). Culture flasks
were kept in a 95% air - 5% CO2 environment at 37°C. Subcul-
tures were obtained within seven to ten day intervals by the above
method. The MC that were used represent an apparently uniform
cell population, as detailed in previous publications from this
laboratory [10—12]. In all experiments the cells from the same
primary culture were used. In these experiments MC only from
the third to eighth passage were used.
Mouse mesangial cells
To have homology between mouse macrophage (Mf) secretory
peptides versus mesangial cells we have carried out cell prolifer-
ation and matrix synthesis studies on mouse mesangial cells
(provided by Prof. Eric G. Neilson, University of Pennsylvania,
Philadelphia, PA, USA) for additional experiments. This cell line
carries all the characteristics of rat mesangial cells.
Morphine (National Institute on Drug Abuse, Bethesda, MD,
USA) was stocked at a concentration of 102 M in normal saline
and used at a concentration of 106 M. Naloxone (NIDA) was
stocked at 10_2 M concentration in normal saline and used in a
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concentration of 10_a M. Anti-TGF-f3 antibodies (R & D Re-
search, Minneapolis, MN, USA) was stocked at I mg/mi and used
in a concentration of 5 xg/ml.
Evaluation of cytotoxic effect of morphine on macrophages
To avoid the potential heterogeneity of elicited rat peritoneal
macrophages, we utilized an established murine macrophage cell
line J774.16 as described previously [13, 141.
To test viability of macrophages as well as cytotoxicity of the
morphine treatment of macrophages we used an (-[4, 5-Dimeth-
ylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Thiazolyl blue)
MIT reaction (Sigma). The MTT reaction is based on the ability
of mitochondrial dehydrogenases to cleave the tetrazolium ring of
the MIT changing the yellowish solution of the water soluble
tetrazolium salt to an insoluble purple formazan. This assay
measures the degree of cytotoxicity in response to a drug [15]. To
determine the cytotoxic effect of morphine on macrophages, cells
were plated in a 96-well plate and allowed to grow to confluence
in Dulbecco's Modified Eagle Medium (DMEM) containing 10%
FCS and 1% penicillin/streptomycin. Cells were washed twice with
phosphate buffered saline and then reincubated in RPM! 1640
(no phenol red) with 10% FCS increasing concentrations of
morphine (10_8 M to iO M) for 24 hours, Reconstituted MIT in
an amount equal to 10% of the final concentration of media was
added to each well and the plate was incubated for a further two
hours. To dissolve the resulting formazan crystals MIT solubili-
zation solution was added in an amount equal to the original
volume of culture medium. The plate was then placed on a shaker
for about 10 minutes to enhance the dissolution and the absor-
bancy was measured at 540 nm to determine differences,
Macrophage culture and collection of control and morphine-
induced macrophage secretory products (conditioned media)
Macrophages were grown in Dulbecco's Modified Eagle Me-
dium (DMEM) containing 10% FCS and either morphine (10_6
M), morphine (10_6 M) + naloxone (10_6 M), or vehicle (control)
on 100 mm diameter plastic culture dishes. Once macrophages
reached confluence (3 to 4 days) the media was removed, cells
washed three times with phosphate buffered saline (PBS) and
media replaced with RPMI 1640 containing penicillin and strep-
tomycin but without FCS. After 24 hours the supernatants were
collected and spun at 1500 rpm for 10 minutes, then filtered (0.2
jim pore size acrodisc). Effects of the control and various condi-
tioned media [containing macrophage secretory products, MSP
(vehicle treated), M-MSP (morphine treated), N + M-MSP
(naloxone + morphine treated)], were evaluated on MC prolifer-
ation and matrix synthesis.
Since macrophages also generate proteases which may degrade
many of the secreted peptides, we prepared fresh batches of
supernatants for each experiment. Some supernatants were pre-
pared by adding protease inhibitors (100 jiM 1, 10-phenanthroline
and 10 jiM dithiothreitol) during the incubation of macrophages in
serum free RPM! (24 hr). These supernatants will be designated
by using the abbreviation M4SP (control) and M-M4SP (mor-
phine treated)
Fluorometric assay for morphine
A morphine fluorometric assay using the Udenfriend method
[16] was performed on MSP and M-MSP to determine if M-MSP
contains any residual of morphine. Briefly, equal amounts of the
supernatants collected in glass conical tubes were dried under
vacuum. Sulfuric acid was added to each tube which was heated at
50°C for five minutes. Five ml of water and 6 ml of ammonium
hydroxide were added as the tubes continued to be heated at 50°C
for two hours. The tubes were then cooled and isobutanol added.
After shaking for four minutes to extract the fluorescence each
sample was read at 420 emission and 365 excitation wavelengths
on a spectrofluorometer.
Mesangial cell proliferation studies
Rat mesangial cells (RMC) were grown to semiconfluence on
96-well plates and then washed twice and incubated with serum-
free RPMI 1640 containing 0.5% BSA and 1% insulin, transferrin
and selenium solution for 72 hours to arrest growth. To determine
the effects of various types of conditioned and control media on
MC proliferation, growth arrested RMC were washed twice with
PBS and incubated with RPMI (without FCS) either alone (CSP)
or containing 50% of various conditioned media for 48 hours. In
previously reported experiments we observed that 50% macro-
phage conditioned media provided optimal growth of mesangial
cells [13, 14]. An aliquot of RPMI containing 0.25 pCi of
[3H]thymidine was added to each well. Six sets of experiments
were performed in triplicate.
To grade the mitogenicity of various conditioned media in
comparison to FCS, subconfluent RMC were growth arrested for
72 hours and washed thrice with PBS. Subsequently, cells were
incubated either with RPMI 1640 alone (CSP), RPMI 1640
containing 1% FCS (FCS), MSP containing 1% FCS (FCS-MSP),
or M-MSP containing 1% FCS (FCS-MMSP) for 48 hours. An
aliquot of RPMI containing 0.25 pCi of [3H]thymidine was added
to each well.
All incubations were carried out at 37°C. At the end of the
incubation period cells were washed three times with cold PBS,
200 jil of 5% trichloroacetic acid (TCA) added to each well and
cells incubated at 4°C for 60 minutes. The TCA supernatant was
removed and 200 jil of 0,25 N NaOH was added to each well. The
cells were kept at room temperature overnight after which the
contents of each well were counted in a scintillation counter.
Results of thymidine incorporation were used as a measure of
cellular proliferation.
To determine the effect of morphine-M4SP on mouse mesang-
ial cell growth, equal numbers of mesangial cells were plated on
24-well plates and allowed to grow to subconfluence. Cells were
growth arrested for 72 hours. Subsequently cells were washed
twice with PBS and incubated in RPMI containing variable
concentrations (5%, 10% and 20%) of either MSP or M-MSP for
48 hours. At the end of the incubation period cells were washed,
trypsinized and counted in a hemocytometer.
To determine the role of TGF-f3 in the M-MSP-induced MMC
proliferation we plated MMC in 24-well plates. After three to four
days, subconfluent MC were growth arrested for 72 hours. Sub-
sequently cells were washed twice with PBS and incubated with
RPMI containing either buffer alone (control), 20% MSP, 20%
M-MSP, 20% M-MSP + anti-TGF-f3 antibody (5 jig/ml), or
anti-TGF-f3 antibody (5 jig/ml) for 48 hours. At the end of the
incubation period, cells were washed, trypsinized and counted in
a hemocytometer. Three sets of experiments (each in triplicate)
were carried out.
To determine the role of naloxone, an opiate receptor ligand, in
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M-MSP induced MC proliferation, subconfluent MMC were
growth arrested for 72 hours. Cells were washed twice with PBS
and incubated in RPMI containing either 20% MSP, 20% M-
MSP, or 20% N-M-MSP for 48 hours. At the end of the
incubation period, cells were trypsinized and counted in a hemo-
cytometer. Three series of experiments were performed, each in
triplicate.
Laminin synthesis
The dot blot immunoassay to determine production of laminin
by RMC treated with control and morphine-treated macrophage
conditioned media was performed using the method of Ayo et al
[171 and Madri, Pratt and Tucker [18]. In brief, MC grown for two
weeks under variable experimental and control conditions were
solubilized, vortexed, centrifuged and a 200 pi aliquot placed on
a 0.45 sm nitrocellulose filter on the dot blot apparatus. In
addition, 1 ng to 100 ng standards of laminin were applied in
triplicate. The membrane was incubated for 30 minutes in Tris-
buffered saline + 0.1% Tween 20 (TTBS). A dilution of rabbit
anti-laminin antibody (Sigma) was added to the solution (1:1000)
and incubation was continued for one hour. After washing for 15
minutes in TIBS, a secondary biotinylated antibody was added at
a concentration of S p.g/ml for a one hour incubation. Following a
second 15-minute wash, Vectastain Elite, an immunoperoxidase
system, was used prior to staining with 4-chloro-naphthol. Rela-
tive absorbancies were measured on an LKB 2202 ultrascan
densitometer attached to an LKB 2220 integrator. A standard
curve was established and laminin concentration determined.
To determine the effect of macrophage supernatant and mor-
phine treated macrophage supernatant on laminin synthesis,
equal numbers of RMCs were plated in six-well culture plates in
incubation medium containing RPMI 1640, 2.5% FCS and 50%
supernatants (MSP and M-MSP) for two weeks. Media was
changed every third day. At the end of the incubation, cells were
washed three times with PBS and scraped for the laminin assay.
An aliquot of scraped cells was used to measure protein by the
method of Bradford [19]. Four sets of experiments were carried
out, each in quadruplicate. Production of laminin was calculated
as ng/jsg or mg of cellular protein.
To evaluate the comparable dose response of MSP and M-
MSP, equal numbers of RMCs were plated on six-well plates in
incubation medium containing RPMI 1640, 2.5% FCS and vari-
able concentrations (10 to 70%) of MSP or M-MSP for two weeks.
Media was changed twice a week. At the end of two weeks, cells
were washed thrice with PBS and scraped from each well.
Measurement of the total amount of laminin and cell protein was
carried out as described above.
To prevent the degradation of peptides in macrophage super-
natants we collected supernatants (M4SP or M-M4SP) in the
presence of protease inhibitors. In order to provide homology to
the mouse macrophage peptides, we used mouse mesangial cells
in these additional experiments. In these experiments, equal
numbers of mouse mesangial cells were plated in six-well plates.
Incubation media contained RPMI + 5% FCS + 10% various
control and macrophage supernatants (prepared in the presence
of protease inhibitor). Cells were incubated in media containing
either control or macrophage supernatants for one week. Incuba-
tion medium was changed every other day. At the end of the
incubation period cells were washed, lysed and laminin and
protein contents in each sample was measured by the above
mentioned method. Four sets of experiments were carried out.
Evaluation of the effect of control, Mf and morphine-Mf
supernatants on synthesis of collagen
Equal numbers (10,000 cells/well) of mouse mesangial cells
were plated in six-well plates. Cells were incubated in media
containing RPMI, 5% FCS and 10% supernatants (control or Mf
or morphine-Mf) for one week. Incubation medium was changed
every other day. At the end of the incubation cells were washed,
lysed and collagen type IV content was measured using the dot
blot assay (in these assays we used anti collagen type IV antibod-
ies in place of antilaminin antibodies). Four sets of experiments
were performed.
Evaluation of the effect of anti-TGF-13 antibodies on morphine-Mf
supernatant-induced collagen synthesis
Equal numbers (6,000 cells/well) of mouse mesangial cells were
plated in six well plates. Cells were incubated in media (RPMI +
5% FCS) containing either 10% Mf supernatant, 10% mor-
phine-Mf supernatant or 10% morphine-Mf supernatant + anti-
TGF-p antibodies (5 tg/ml) for one week. Incubation medium
was changed every other day. At the end of the incubation period
cells were washed, lysed and collagen contents were measured by
the dot blot assay. Five series of experiments were carried out.
Mesangial RNA extraction and identification of TGF-13
Northern blot analysis of mRNA for TGF-j3 was performed on
RPMI (control), 50% MSP and 50% M-MSP treated MC, grown
in 100 mm cell culture dishes until confluent (one week). Total
RNA was extracted from lysates of confluent MCs by the method
of Chomczynski and Sacchi [20]. Aliquots of total RNA were
treated with glyoxal and DMSO, electrophoresed in a 1% agarose
gel, and transferred to nitrocellulose membranes. RNA ladder
was included and the gel was stained with ethidium bromide to
determine the size of RNA. cDNA probes specific for TGF-/3 (R
& D Systems) was used for hybridization after [32P]cICTP labeling
by random-prime labeling. Filters were prehybridized at 50°C for
three hours and then hybridized at 65°C for 16 hours with the
labeled eDNA probe. The membranes were washed under strin-
gent conditions with 2 X SSC and 1% SDS at 65°C. After washing,
the membranes were kept in contact with XAR-5 film and
intensifying screen at —70°C and developed. The membranes
were washed to remove the hybridized probe and reprobed with
GAPDH to ascertain that similar amounts of RNA were applied
to the gel.
Effect of anti-TGF-f3 antibodies on mRNA expression for TGF-f3
on mesangial cells
To determine the effect of TGF-p on mRNA expression for
TGF- in mesangial cells we incubated confluent cells in incuba-
tion medium containing either buffer alone (control), 50% MSP,
50% MSP + anti-TGF-j3 antibody (5 xg/ml), 50% M-MSP, or
50% M-MSP + anti-TGF- antibody (5 jsg/ml) for 24 hours. At
the end of the incubation period cells were washed and total RNA
was extracted. An equal amount (20 jxg) of RNA for each
experimental condition was used to determine mRNA expression
for TGF-13 on mesangial cells by the above mentioned method.
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Control
Morphine
10" M 10-6 M i0' M
Absorbance 0.623
0.010
0.655"
0.0.17
0.589
0.032
0.531a
0.025
Macrophages were grown to confluence in a 96-well plate. Cells were
washed twice with phosphate buffered saline and then reincubated in
RPMI 1640 (no phenol red) with 10% FCS increasing concentrations of
morphine (10" M to 1O M) for 24 hours. MIT in an amount equal to
10% of the final concentration of media was added to each well and the
plate was incubated for a further two hours. At the end of the incubation
period, formazan crystals were solubilized and the absorbency was mea-
sured at 540 nm to determine differences. Results represent means SEM
from 16 wells for each variable. To compare values between multiple
groups, analysis of variance was applied and a Newman-Keuls multiple
range test was used to calculate a q value.
P < 0.05 compared with control
hp < 0.01 compared with morphine iO- M
Statistical analysis
For comparison of mean values between two groups an un-
paired t-test was used. To compare values between multiple
groups analysis of variance (ANOVA) was applied. A Newman-
Keuls multiple range test was used to calculate a q value. All
values are reported as mean SEM except where otherwise
indicated. Statistical significance was defined as P < 0.05.
Results
Fluorometric assay of moiphine in supernatants
MSP as well as M-MSP did not show any presence of morphine.
Thus, morphine does not seem to play a direct role in M-MSP-
induced mesangial cell growth.
Cyotoxic effect of morphine on macrophages
The effect of morphine on macrophages is shown in Table 1.
Morphine in concentrations of 106 to 108 M did not show any
cytotoxic effect on macrophages. However, morphine in a higher
concentration (10—a M) showed decreased mitochondrial dehy-
drogenases activity (Table 1).
Effect of interaction between morphine and macrophages on
mesangial cell proliferation
Macrophage secretory products (MSP) significantly enhanced
(P < 0.001) RMC proliferation when compared with control cells
(control, 127.3 3.4 vs. 453.1 cpm/xg protein). Mesangial cells
that were incubated with M-MSP demonstrated significantly
higher levels (P < 0.01) of [3Hlthymidine incorporation when
compared with RMC treated with MSP (MSP, 453.1 25.6 vs.
M-MSP, 591.6 30.1 cpm/jxg protein). These results indicate that
macrophage secretory products enhance RMC proliferation. Ac-
tivation of macrophages by morphine appears to further enhance
the mitogenic effect of MSP on MC proliferation.
In another set of experiments, RMCs after growth arrest were
incubated in RPMI 1640 alone (CSP), RPMI 1640 containing 1%
fetal calf serum (FCS), RPMI 1640 + 1% FCS + MSP (FCS-
MSP) or RPMI 1640 + 1% FCS + M-MSP (FCS-MMSP) for 24
hours and pulsed with [3H]thymidine. The effect of FCS, FCS-
MSP and FCS-M-MSP on RMC proliferation is shown in Figure
Fig. 1. Comparison of the effect of FCS, MSP and M-MSP on mesangial cell
proliferation. Mesangial cells that were grown to subconfluence and growth
arrested for 72 hours were incubated either with RPMI 1640 alone (CSP),
RPMI 1640 + 1% FCS (FCS), RPMI 1640 + 1% FCS + 50% MSP
(FCS-MSP), or RPMI 1640 + 1% FCS + 50% M-MSP (FCS-MMSP) for
48 hours. A 0.25 Ci aliquot of [3H]thymidine was added to each well and
thymidine incorporation as a marker of DNA synthesis was determined.
Results represent mean SEM from six series of experiments carried out
in triplicate. A Newman-Keuls multiple range test was used to calculate a
q value.
Cell count 22.5 22.4 22.9 36.3° 23.1 418b,C
lO cells/well
0.6 0.7 0.3 2.0 0.2 0.4
Equal numbers of mouse mesangial cells were grown to semiconfluence
on 24-well plates and then growth arrested for 72 hours. Subsequently,
cells were washed twice with PBS and incubated in RPMI containing
variable concentrations (5%, 10% and 20%) of either M4,SP or M-M4SP
for 48 hours at 37°C. At the end of the incubation period cells were
washed, trypsinized and counted in a hemocytometer. Results represent
means SEM from three sets of experiments performed in quadruplicate.
A Newman-Keuls multiple range test was used to calculate a q-value.
ap < 0.01 compared with 10% M4)SP and 5% M-MSP
bp < 0.001 compared 20% M4SP and 5% M-M4SP
P < 0.05 compared 10% M-M4SP
1. FCS increased (sixfold) DNA synthesis when compared to
control cells. Morphine treatment of macrophages (FCS-MMSP)
enhanced (P < 0.01) RMC proliferation when compared with
FCS or FCS-MSP (FCS-MSP, 834.6 32.0 vs. FCS-MMSP, 1,170
50.3 cpm/ jig protein). These results suggest that M-MSP has an
additive action on the growth promoting effect of fetal calf serum.
Effect of M-M4SP on proliferation of mouse mesangial cells
The effect of M-M4SP on mouse mesangial cell proliferation is
shown in Table 2. M-M4SP enhanced proliferation of mouse
mesangial cells at 10% and 20% concentrations. This effect of
M-MSP was dose dependent. Since the mitogenic effect of
M-M4SP was obvious at lower concentrations (10% concentra-
tion), it appears that perhaps M-M4SP has a higher concentration
of growth promoting factors.
Table 1. Cytotoxic effect of morphine on macrophages
12.0
9.0
.
6.0
>, ,-.
.c 3.0I
0
CSP FCS FCS-MSP FCS-MMSP
Table 2. Effect of morphine treated mouse macrophage supernatant on
mouse mesangial cell proliferation
Mouse macrophage supernatants
5% 10% 20%
M4SP M-Mq5SP M4'SP M-M4SP MSP Mçb-MSP
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Table 4. Effect of naloxone on M-MSP induced mesangial
cell proliferation
MSP M-MSP N + M-MSP
Cell count 9.4 16.Oa 13.6
>< io cells/mi
1.0 0.2 1.6
Equal numbers of mouse mesangial cell were plated in 24-well plates
and grown to subconfluence. MMC were growth arrested for 72 hours.
Cells were washed twice with PBS and incubated in RPMI containing
either 20% MSP, 20% M-MSP, or 20% N-M-MSP for 48 hours. At the
end of the incubation period, cells were trypsinized and counted in a
hemocytometer. Results (means SEM) are from three series of experi-
ments, each performed in triplicate. To compare values between multiple
groups analysis of variance (ANOVA) was applied. A Newman-Keuls
multiple range test was used to calculate a q value.
a P < 0.05 compared with MSP
M-MSP+ Anti-
Control MSP M-MSP anti-TGF-/3 ab TGF-/3 ab
Fig. 3. Effects of M-MSP on the synthesis of laminin. Equal numbers of
mesangial cells were plated and incubated in growth medium containing
either 50% MSP (MSP) or 50% M-MSP (M-MSP) for two weeks. Media
was changed twice a week. At the end of two weeks cells were harvested
and the amount of laminin was determined by a dot blot assay. Results
represent means SEM (ng/xg cell protein) from four series of experi-
ments carried out in triplicate. *p < 0.05 compared to MSP.
mitogenic effect of M-MSP on mesangial cells (control, 9.4 1.0,
M-MSP, 16.0 0.2, naloxone + M-MSP, 13.6 1.6 X i04
cells/mi).
Effect of MSP and M-MSP on synthesis of laminin
The effect of MSP and M-MSP on laminin synthesis by RMC is
shown in Figure 3. M-MSP increased (P < 0.05) mesangial
synthesis of laminin when compared with cells treated with MSP
alone. These results indicate that morphine increases laminin
cell proliferation synthesis by RMC.
Dose response effect of MSP and M-MSP
The comparable effect of variable concentrations (10% to 70%)
of MSP and M-MSP on the synthesis of laminin is shown in Table
5. M-MSP enhanced the synthesis of laminin at concentrations of
10% to 50% when compared to MSP alone. A dose response
effect of M-MSP on laminin synthesis by RMC is shown in Figure
4. M-MSP increased synthesis of laminin in a dose dependent
manner. M-MSP increased maximal synthesis of laminin by RMC
at a concentration of 50%.
**
*
a
CSP MSP M-MSP M-MSP Anti-TGF-ab
25
20
15
x
• 10
00
0
0
÷ +
Anti-TGF-ab CSP
Fig. 2. Effect of anti-TGF-13 antibody on mesangial cell proliferation. Sub-
confluent MC were growth arrested for 72 hours. Cells were incubated
with RPMI containing either buffer alone (control, CSP), 50% MSP, 50%
M-MSP, 50% M-MSP + anti-TGF-f3 antibody (5 xg/m1), or anti-TGF-/3
antibody (5 j.rg/ml) for 48 hours. At the end of the incubation period, cells
were washed, trypsinized and counted in a hemocytometer. Results
(means SEM) are from three series (each carried out in triplicate) of
experiments. To compare values between multiple groups analysis of
variance (ANOVA) was applied. A Newman-Keuls multiple range test
was used to calculate a q value. < 0.01 compared with control; ** <
0.001 compared with control; ap < 0.001 compared with CSP; <
0.001 compared with M-MSP.
Table 3. Effect of anti-TGF-p antibody on M-MSP-induced mesangial
cell proliferation
. 2.25
ci)
e0.
0)
p2.0
1.75
Cl)
C
E
Cci
_' 0
Cell count 14.1 18.2a 218hc 14.2 79h
X iO ceils/ml
0.8 0.3 1.2 0.3 0.1
MSP M-MSP
Equal number of mouse mesangial cells were plated in 24-well plates.
After 3 to 4 days, subconfluent MC were growth arrested for 72 hours.
Subsequently cells were incubated with RPMI containing either buffer
alone (control), 50% MSP, 50% M-MSP, 50% M-MSP + anti-TGF-
antibody (5 /LgIml), or anti-TGF-/3 antibody (5 j.rg/ml) for 48 hours. At the
end of the incubation period, cells were washed, trypsinized and counted
in a hemocytometer. Results (means SEM) are from three sets of
experiments, each carried oot in triplicate. To compare values between
multiple groups analysis of variance (ANOVA) was applied. A Newman-
Keuls multiple range test was used to calculate a q value.
P < 0.01 compared with control
h P < 0.001 compared with control
P < 0.05 compared with MSP
d P < 0.001 compared with M-MSP
Effect of anti- TGF-/3 antibody on M-MSP-induced mesangial
The effect of anti-TGF-13 antibody on M-MSP-induced MC
proliferation is shown in Figure 2 and Table 3. M-MSP enhanced
(P < 0.001) mesangial cell proliferation when compared with
control (control, 14.1 0.8 vs. M-MSP, 21.8 1.2 X i0 cells/mi).
Anti-TGF-f3 antibody attenuated the effect M-MSP on mesangial
cell growth (Table 3).
Effect of naloxone on M-MSP-induced mesangial cell proliferation
The effect of naloxone on M-MSP-induced mesangial cell
proliferation is shown in Table 4. Naloxone did not attenuate the
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Table 5. Dose response effect of morphine and macrophage interaction on laminin synthesis by mesangial cells
% Supernatant
variable
10% 30%
MSP M-MSP
50%
MSP M-MSP
70%
MSP M-MSP MSP M-MSP
Mean ng/mg protein 99.0 174.0a 127.0 195.0" 126.0 312.Oa 168.0 235.0
SEM 6.0 5.0 16.0 13.0 19.0 14.0 39.0 30.0
Equal numbers of mesangial cells were plated on six-well plates in incubation medium containing RPMI 1640 + 2.5% fetal calf serum and variable
concentrations (10% to 70%) of control or morphine treated macrophage supernatant and cells were allowed to grow for two weeks. Media was changed
every third day. At the end of the incubation cells were scraped from each well and a dot blot assay carried out to measure the total amount of laminin.
Results represent means SEM from four sets of experiments.
P < 0.001 compared with respective controlsbP < 0.02 compared with respective control
0
Morphine treated macrophage supernatant, %
Fig. 4. Dose response effect of M-MSP on the synthesis of laminin. Equal
numbers of mesangial cells were plated on six-well plates. Cells were
incubated in growth medium containing 0 to 70% morphine treated
macrophage supernatant for two weeks. At the end of the incubation
period, cells were harvested and the amount of laminin was measured by
dot blot assay. Results represent means SEM (ng/mg of protein) from
four series of experiments.
Effect of M-Md>SP on laminin synthesis by mouse mesangial cells
The effect of M-Md)SP on the synthesis of laminin by mouse
mesangial cells (MMC) is shown in Table 6. M4SP enhanced (P <
0.01) the synthesis of laminin by MMC. M-Md)SP increased (P <
0.001) synthesis of laminin when compared with control cells as
well as MSP treated cells.
Effect of M-Md)SP on collagen synthesis by mouse mesangial cells
The effects of control, Md>SP and M-MjSP on the synthesis of
collagen type IV by mouse mesangial cells are shown in Table 7.
Mouse mesangial cells treated with M-Md)SP showed a greater
(P < 0.01) amount of collagen synthesis when compared with
control and Md>SP treated cells.
Effect of anti-TGF- antibodies on M-M4SP-induced
collagen synthesis
The effect of anti-TGF-/3 antibodies on M-Md>SP-induced
collagen synthesis is shown in Figure 5. M-Md>SP enhanced (P <
0.05) the synthesis of collagen by MMC when compared to Md>SP
treated cells. However this effect of M-Md)SP was inhibited (P <
0.05) when cells were also treated with anti-TGF-f3 antibodies
(MSP, 1149.4 35.7, M-Md>SP, 1515.1 82.7, anti-TGF-f3
antibodies + M-M4SP, 1068.9 131.0 ng collagen/mg protein).
Control Md> Morphine-Md>
supernatant supernatant supernatant
Laminin 919.1 20.2 1379.4 68.3' 1999.8 79.4'
ng/mg protein
Control Morphine-
supernatant Md> supernatant Md> supernatant
Collagen type IV 1698.7 81.6 1735.7 93.1 2412.9 121.2k'
ng/mg protein
Equal number of mouse mesangial cells were grown in medium
containing either 10% control supernatant, 10% Md> supernatant, or 10%
morphine-Md> supernatant for one week. Incubation medium was changed
every other day. At the end of the incubation period cells were washed,
lysed and collagen type IV contents were measured (dot blot assay).
Results represent means SEM from 4 series of experiments. To com-
pare values between the groups analysis of variance (ANOVA) was
applied. A Ncwman-Keuls multiple range test was used to calculate a q
value.
a P < 0.01 compared with control and Md> supernatants
These results indicate that M-M4SP-induced enhanced synthesis
of collagen may be mediated through TGF-13.
Effect of MSP and M-MSP on mRNA expression for TGF-f3 on
mesangial cells
The effect of control supernatant (CSP), MSP and M-MSP on
mRNA expression for TGF-/3 on RMC is shown in Figure 6. RMC
treated with M-MSP showed increased expression of mRNA for
TGF-13 when compared with mesangial cells treated with MSP or
CSP. These results suggest that morphine activates macrophages
to induce enhanced synthesis of TGF-/3 by mesangial cells.
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Table 6. Effect of morphine-Md) supernatant on synthesis of laminin by
mouse mesangial cells
Equal number of mouse mesangial cells were grown in medium
containing either 20% control supernatant, 20% Md> supernatant, or 20%
morphine-Md> supernatant for one week. The medium was changed every
3rd day. At the end of the incubation period cells were washed, lysed and
measurement of laminin and protein was carried out. Results (means
5EM) are from 4 sets of experiments. To compare values between the
0 10 30 50 70 groups analysis of variance (ANOVA) was applied. A Newman-Keuls
multiple range test was used to calculate a q value.
a P < 0.01 compared with control
b P < 0.001 compared with control and Md> supernatant
Table 7. Effect of morphine-Md> supernatant on synthesis of collagen
type IV by mouse mesangial cells
100 Singhal et al: Morphine and mesangial expansion
The effect of anti-TGF- antibodies on MSP and M-MSP
induced mRNA expression for TGF-p on MC is shown in Figure
7. Densitometric evaluation of these bands did not show any
decrease in mRNA expression for TGF-13 on MC in anti-TGF-3
antibody treated samples.
Discussion
The present study clearly demonstrates that morphine-induced
macrophage secretory products stimulates proliferation of rat as
well as mouse mesangial cells. Morphine-induced macrophage
products also enhanced the synthesis of laminin by both types of
mesangial cells. This effect of M-MSP was dose dependent.
M-MSP also enhanced the synthesis of type IV collagen by
mouse mesangial cells. This effect of M-M4SP on collagen
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synthesis was attenuated by anti-TGF- antibodies. Moreover, the
interaction between morphine and macrophages also enhanced
the expression of mRNA for TGF-13 on mesangial cells. It appears
that the effect of M-MSP on MC may be mediated through the
generation of TGF-p by MC.
There is increasing evidence which suggest that macrophage
infiltration contributes to the progression of glomerulosclerosis
[4—9]. Saito and Atkins in the experimental model of puromycin
aminonucleoside (PAN)-induced nephrosis showed significant
infiltration of macrophages in the glomeruli when the sclerotic
lesion appeared [21]. In the PAN model, depletion of glomerular
macrophages by essential fatty acid deficient diets ameliorated
acute renal dysfunction [71. In the same model, timed systemic
X-irradiation also attenuated the late development of glomerulo-
sclerosis [4, 5]. These authors emphasized the role of macro-
phages in the development of FGS in the PAN model. Van Goor
et al [8] demonstrated glomerular macrophage influx as a major
structural alteration associated with FGS in the setting of renal
ablation. In their later experiments these investigators induced
sustained glomerular macrophage depletion in remnant kidney
rats by a regimen of sublethal triple irradiation. In these experi-
ments, histologic examination showed a significant decrease in
mesangial cell proliferation and mesangial matrix expansion in
glomeruli of X-irradiated rats when compared with non-irradiated
remnant kidney rats [9]. However, in the late stage in X-irradiated
rats glomeruli showed influx of macrophages which was associated
with the expansion of the mesangium [9]. Thus macrophages seem
to play an important role in the progression of FGS in models of
PAN-induced nephrosis and renal ablation.
Cytokines have been considered to be important mediators in
macrophage associated glomerular injury [6, 22]. TGF-p has been
shown to play a significant role in the pathogenesis of anti-Thy
1.1-induced mesangial expansion [22]. Ding, Pesek-Diamond [6]
in the model of PAN-induced nephrosis showed that increased
glomerular macrophage influx was also associated with increased
glomerular mRNA expression for TGF-131. Other macrophage
cytokines which have evidence of contributing to glomerular
inflammation are TNF-a and IL-i. However, these cytokines
(TNF and IL-I) have been demonstrated to play an important
role in proliferative glomerulonephritis [22]. Their role in FGS is
not clear.
*
MSP M- MOSP M- MOSP Fig. 7. Northern blots for mRNA expression on mesangial cells TGF-f3 (2.56
+ kb). Confluent mouse mesangial cells were incubated either with buffer
Anti-TGF (control), 50% MSP, 50% MSP + anti-TGF-/3 antibody (ATGF-j3ab, 5
- 3 antibody xg/ml), 50% M-MSP, or anti-TGF-13 antibody (5 g/ml) + 50% M-MSPfor 24 hours. Total RNA was extracted and 20 jg of RNA was used for
each lane.
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Fig. 5. Effect of anti-TGF-13 antibodies on M-MçtSP-induced collagen
synthesis. Equal numbers of mouse mesangial cells were incubated in
medium (RPMI + 5% FCS) containing either 10% MSP, 10% M-M4SP,
or anti-TGF- antibodies (5 jxg/ml) + 10% M-M4SP for one week. At the
end of the incubation period cells were lysed and collagen contents were
measured. Results represent means SEM from 5 sets of experiments. To
compare values between multiple groups, analysis of variance was applied
and A Newman-Keuls multiple range test was used to calculate a q value.
*D < 0.05 compared with MSP and M-M4SP + anti-TGF- antibodies.
TGF- —2.5kb
GADPH
—1.4 KB
Fig. 6. Northern blots of TGF-f3 (upper panel) and GAPDH (lower panel).
mRNA expression on mesangial cells after a one week exposure to
incubation medium alone (C), incubation media containing either 50%
macrophage supernatant (MSP) or 50% morphine treated macrophage
supernatant (M-MSP).
Effect of anti-TGF-13 antibodies on mRNA expression for TGF-/3
on mesangial cells
C MSP M-MSP
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TGF-p has been isolated from bovine kidney [23], rat kidney
fibroblasts [24] and mesangial cells [25]. Glomerular cells have
been demonstrated to express specific receptors for TGF-f3 [25].
Although TGF-13 inhibited proliferation of glomerular endothelial
and epithelial cells it acted as a bifunctional regulator of mesang-
ial cell proliferation [25]. TGF-/3 has also been shown to have a
direct effect on the synthesis of mesangial matrix [22]. Since other
growth factors produced by macrophages including, interleukin-1
and tumor necrosis factor, have been demonstrated not to have a
significant effect on the synthesis of matrix components [22], we
believe that the M-MSP induced effect on the synthesis of matrix
components was related to the increase in the production of
TGF-/3 by activated macrophages.
The effects of morphine on immunomodulation have been
shown to be mediated through opiate receptors on monocytes and
lymphocytes [26, 27]. The molecular mechanism responsible for
the effect of morphine is not clear. However, TGF-13 antibodies
inhibited the effect of opiates on the respiratory burst activity in
porcine peripheral blood monocyte cultures [28]. TGF-f3 has also
been reported to be a potent monocyte/macrophage inhibitor of
respiratory burst activity of these cells in many species, including
rodents, and swine [27, 29]. All these studies suggest that TGF-J3
may be a mediator of some of the effects exerted by opiates on
monocytes/macrophages. Recently, Chao et al [30] demonstrated
that morphine enhances the release of TGF-f3 by mononuclear
cell cultures. The present study showing enhanced mRNA expres-
sion for TGF-p on mesangial cells by morphine treated macro-
phagc secretory products provides a basis for speculation by which
morphine can contribute to the expansion of the mesangium.
The development of glomerulosclerosis in patients with heroin
addiction has been attributed to a variety of factors [3 1—36]. The
majority of patients with heroin nephropathy are black [31]. It has
been suggested that the Negroid race has a genetic predisposition
to develop heroin nephropathy [32]. Recently, Friedman and Rao
reported a decline in the prevalence of heroin nephropathy in
their hospital [33]. These authors attributed this decline to the
availability of pure heroin in the market. These investigators
suggested that heroin impurities may be playing a role in the
higher incidence of heroin nephropathy in the past. However, a
significant number of patients with HIV infection who develop
focal glomerulosclerosis are also drug addicts [34]. It appears that
drugs and HIV infection may be playing a synergistic role in the
development of glomerulosclerosis. Both drugs and HIV modu-
late the immune system and predispose persons to hepatitis and
opportunistic infections [27, 35]. Many of these infectious agents
including hepatitis B and cytomegalo virus have been demon-
strated to cause damage to the kidney [36].
We conclude that morphine-induced macrophage secretory
products stimulate proliferation of mesangial cells. They also
enhance the synthesis of laminin and collagen type IV by mesang-
ial cells. This action of morphine on mesangial cells seems to be
partly mediated through TGF-p. The present study suggests a
possible role for macrophages in the development of glomerular
lesions in patients with drug addiction.
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